Chinese commercial space launch service provider LandSpace has raised a RMB500 million ($71 million) Series C led by the VC arm of Hong Kong-listed property developer Country Garden.
Proceeds will go to the development of a new launch vehicle – the Zhuque-2 – which will use a liquid oxygen and liquid methane propellant system. LandSpace claims Zhuque-2 as China's first middle to...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.